Compare NVR & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVR | DVA |
|---|---|---|
| Founded | 1980 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5B | 14.9B |
| IPO Year | 1995 | 2003 |
| Metric | NVR | DVA |
|---|---|---|
| Price | $6,303.34 | $179.87 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $7,157.80 | $156.75 |
| AVG Volume (30 Days) | 27.4K | ★ 936.0K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 151.38 | 6.86 |
| Revenue | $10,323,959,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | N/A | $3.85 |
| Revenue Next Year | $6.60 | $3.07 |
| P/E Ratio | $42.49 | ★ $26.00 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $5,501.01 | $101.00 |
| 52 Week High | $8,618.28 | $247.49 |
| Indicator | NVR | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 22.17 |
| Support Level | $6,304.01 | $145.58 |
| Resistance Level | $6,893.60 | $202.63 |
| Average True Range (ATR) | 174.98 | 8.05 |
| MACD | 9.84 | -7.32 |
| Stochastic Oscillator | 58.06 | 2.00 |
NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.